Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour <scp>DNA</scp> of stage <scp>II–IIIA NSCLC</scp> patients-Reference-Cited by-同舟云学术

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients

Published:2022-06-27 Issue:14 Volume:16 Page:2719-2732
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Vessies Daan C. L.¹^ORCID,Schuurbiers Milou M. F.²,van der Noort Vincent³,Schouten Irene⁴,Linders Theodora C.¹,Lanfermeijer Mirthe¹,Ramkisoensing Kalpana L.¹,Hartemink Koen J.⁵,Monkhorst Kim⁶,van den Heuvel Michel M.²,van den Broek Daan¹

Affiliation:

1. Department of Laboratory Medicine Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

2. Department of Pulmonology Radboud University Medical Center Nijmegen The Netherlands

3. Biometrics Department Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

4. Department of Thoracic Oncology Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

5. Department of Surgery Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

6. Department of Pathology Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

Funder

Roche Diagnostics

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13267

Reference39 articles.

1. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

2. Netherlands Cancer Registry (NKR).2018.Aantal nieuwe gevallen van longkanker 2018.

3. Stage at diagnosis and early mortality from cancer in England

4. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

5. Adjuvant chemotherapy in patients with completely resected nonsmall cell lung cancer;Pirker R;Transl Lung Cancer Res,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of ctDNA in early breast cancer: analytical validity and clinical potential;npj Breast Cancer;2024-06-19

2. Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations;ESMO Gastrointestinal Oncology;2024-06

3. In vitro size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies;The Journal of Liquid Biopsy;2024-06

4. Fragmentomics features of ovarian cancer;International Journal of Cancer;2024-05-20

5. Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum;Biomedical Journal;2024-03